Stephen Ellis, M.D., professor of medicine and director of interventional cardiology at Cleveland Clinic, discusses the two year outcomes of the ABSORB III trial of Absorb vs. Xience.
Stents Bioresorbable
-
-
-
One of the big advancements in drug-eluting stent (DES) technology has been the development of bioresorbable polymers that disappear and leave behind a bare metal stent.
-
The Diagnostic and Interventional Cardiology (DAIC) website had a record year in 2016, breaking 1 million page views for the first time.
Videos | Stents Bioresorbable | March 30, 2017
Stephen Ellis, M.D., professor of medicine and director of interventional cardiology at Cleveland Clinic, discusses...
Feature | Stents Bioresorbable | March 21, 2017 | Dave Fornell
March 21, 2017 — In the late-breaking ABSORB III Trial two year results presented at the American College...
Blog | Stents | February 13, 2017
Stents were the key focus of interventional cardiology for more than 20 years, but the focus has changed in recent...
Blog | January 30, 2017
DAIC has worked hard to bring useful technology news and resources to our readers. While we conduct reader surveys...
The Synergy stent is the first FDA cleared drug-eluting stent to use a bioresorbable polymer drug carrier. When the polymer dissolves after about four months, the devices become a bare metal stent. The technology is supposed to reduce the rate of late stent thrombosis due to vessel inflammation caused by durable polymers.
Feature | Stents Bioresorbable | January 17, 2017 | Dave Fornell
One of the big advancements in drug-eluting stent (DES) technology has been the development of bioresorbable...
An OCT image showing good stent strut apposition against the vessel wall.
News | Stents | January 13, 2017
January 13, 2017 — Results from TRANSFORM-OCT, a prospective, randomized trial using optical coherence tomography (...
The FDA clearance of the first fully bioresorbable stent, the Abbott Absorb BVS, was by far the top story of 2016. Readers clearly had a massive interest in this technology based on their page views of this article, related bioresorbable stent content and a video interviews with key ABSORB study investigators.
Feature | December 21, 2016 | Dave Fornell
The Diagnostic and Interventional Cardiology (DAIC) website had a record year in 2016, breaking 1 million page views...
Videos | Stents Bioresorbable | November 09, 2016
Juan Granada, M.D., executive director and chief scientific officer of the Cardiovascular Research Foundation's...
Biotronik's Osiro ultra-thin strut, sirolimus-eluting stent.
News | Stents | November 09, 2016
November 9, 2016 – Results from a randomized, multicenter trial failed to show non-inferiority of hybrid, ultra-thin...
OCT imaging showing neointimal tissue coverage of metallic stent struts.
News | Stents | November 07, 2016
November 7, 2016 – Results from TRANSFORM-OCT, a prospective, randomized trial using optical coherence tomography (...
The Fortitude sirolimus-eluting bioresorbable stent.
News | Stents Bioresorbable | November 07, 2016
November 7, 2016 — The 28th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, Oct. 29-Nov...
News | Stents | October 28, 2016
October 28, 2016 — Svelte Medical Systems Inc. announced this week it received CE Mark certification of the Direct...
A comparison of how the Abbott Absorb BVS appears with intravascular ultrasound (IVUS) on the left, and optical coherence tomography (OCT) of the right. The stent is difficult to visualize and sizing is critical, so both modalities can help in bioresorbable stent measurements and to confirm stent apposition. Left image from the Volcano IVUS system and the right image from St. Jude Medical's OCT system
Feature | Stents Bioresorbable | October 20, 2016 | Dave Fornell
There has been a lot of interest in the interventional community regarding the Abbott Absorb Bioresorbable Vascular...
Feature | Cath Lab | September 28, 2016
September 28, 2016 — The Cardiovascular Research Foundation (CRF) included 11 late-breaking trials and 16 first...
An optical coherence tomography (OCT) image of an Absorb bioresorbable stent. The stent struts are clear, allowing light to pass through, and in some cases magnifying the light that passes through under each strut. Image courtesy of St. Jude Medical.
Blog | Stents Bioresorbable | August 16, 2016
There was an explosion of interest in bioresorbable stents immediately following the July 5, 2016 announcement that...
